Real-time enrollment status for this dialysis amyloidosis clinical trial
Current Status
Suspended
Checked: September 1, 2026 at 4:47 PM UTC
| NCT Number | NCT02952144 |
| Recruiting Status | Suspended |
| Condition | Dialysis Amyloidosis |
| Phase | NA |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Kaneka Medical America LLC |
| Last Updated on CT.gov | August 31, 2026 (Yesterday) |
As of September 1, 2026: Clinical trial NCT02952144 is currently suspended participants. This na study for dialysis amyloidosis is not currently accepting new participants at 1 location across the United States. The study is sponsored by Kaneka Medical America LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT02952144 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02952144 was last updated Yesterday (August 31, 2026). HelloStudys verifies this status automatically.